Kartesia provides financing for German Investor-backed pharma services firm

Kartesia, the European specialist in capital solutions for small and mid-sized enterprises, is pleased to announce a new transaction involving a leading player in the pharmaceutical services sector.

This business is a top-tier provider of commercialization solutions for pharmaceutical and healthcare clients, offering a fully integrated suite of services including sales outsourcing, medical support, and marketing and communications. Recognized as a market leader in Germany, it is a trusted partner to blue-chip clients, consistently delivering high-quality and reliable services.

Kartesia’s investment involved a tailored and swiftly executed solution to meet the Investor’s specific requirements, building on a trusted relationship from prior collaborations.

The capital was deployed from the Kartesia Senior Opportunities (KSO) strategy. The deal team at Kartesia consisted of Benjamin Schall, Nico Wellm, Marvin Knopp and Daniel Kaltenecker.

Nico Wellm, Investment Manager at Kartesia, commented: “We are delighted to close the Munich team’s fourth deal this year, highlighting Kartesia’s strong momentum in the DACH region. Our flexible financing solution empowers a key industry player to further consolidate its leadership in the German pharmaceutical services market through both organic growth and strategic acquisitions.”